RecruitingNCT06449404
7.0T Magnetic Resonance Imaging Study of Parkinson's Disease
Sponsor
Chinese PLA General Hospital
Enrollment
200 participants
Start Date
Mar 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
This clinical trial study is conducted to detect the imaging characteristics of the patients with Parkinson's diseases (PD) by 7-Tesla (7T) magnetic resonance imaging (MRI).
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Inclusion Criteria1
- the patients with PD who was diagnosed by the experienced neurologist specializing in movement disorders
Exclusion Criteria3
- the patients with brain disorders such as cerebrovascular disease, brain tumors, epilepsy, other neurodegenerative disease;
- psychiatric disorders with impaired cognitive function;
- contraindications to MRI.
Interventions
OTHER7T-MRI scaning
7T-MRI scaning
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06449404
Related Trials
A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk Factors for Decompensation in Liver Cirrhosis
NCT072911411 location
Serial MRI Scans During Radiation Therapy
NCT041885352 locations
Detection and Metabolic Characterization in DOPA PET/CT of Brain Metastases
NCT048900283 locations
Exploring the Correlation Between MRI Image Characteristics and Diagnosis, Pathology and Prognosis in Patients With Prostate Lesions
NCT069467711 location
The BRAINMAP-DBS Study: BRain Network AnalysIs usiNg 7-Tesla MRI and MAgnetoencephalograPhy for Deep Brain Stimulation
NCT069326921 location